Nxera Pharma Co (Nxera Pharma Co) Other Long Term Assets : $41.5 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Nxera Pharma Co Other Long Term Assets?

Nxera Pharma Co's other long-term assets for the quarter that ended in Mar. 2024 was $41.5 Mil.

Nxera Pharma Co's quarterly other long-term assets increased from Sep. 2023 ($34.4 Mil) to Dec. 2023 ($50.5 Mil) but then stayed the same from Dec. 2023 ($50.5 Mil) to Mar. 2024 ($41.5 Mil).

Nxera Pharma Co's annual other long-term assets declined from Dec. 2021 ($54.0 Mil) to Dec. 2022 ($13.3 Mil) but then increased from Dec. 2022 ($13.3 Mil) to Dec. 2023 ($50.5 Mil).

Nxera Pharma Co Other Long Term Assets Historical Data

The historical data trend for Nxera Pharma Co's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nxera Pharma Co Other Long Term Assets Chart

Nxera Pharma Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long Term Assets

Get a 7-Day Free Trial

51.63

45.16

53.98

13.35

50.51

Nxera Pharma Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long Term Assets	Get a 7-Day Free Trial															12.97	15.80	34.39	50.51	41.45

Nxera Pharma Co Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Nxera Pharma Co (Nxera Pharma Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nxera Pharma Co Ltd (OTCPK:SOLTF) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

4565:Japan JSS:Germany

Address

2-1 Kojimachi, Chiyoda-ku, PMO Hanzomon 11th Floor, Tokyo, JPN, 102-0083

Website

http://www.sosei.com

Sosei Group Corp is an international biopharmaceutical company that develops treatments for a wide range of illnesses. The company utilizes its peptide platform technologies and nanotechnology to develop its product pipeline. Sosei actively seeks partnerships to aid its product development. The company's strategy for commercializing its therapies include utilizing its subsidiaries' drug discovery technologies, supplying technology to other companies, developing products in-house, and product licensing.